Harvard Bioscience (NASDAQ:HBIO) Earns Hold Rating from Analysts at StockNews.com
Equities researchers at StockNews.com started coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the medical instruments supplier’s stock. Other research analysts have also recently issued reports about the company. KeyCorp reiterated a “sector weight” rating on […]
Equities researchers at StockNews.com started coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the medical instruments supplier’s stock. Other research analysts have also recently issued reports about the company. KeyCorp reiterated a “sector weight” rating on […]
